Sherwood A L, Holmes E H
Northwest Hospital, Pacific Northwest Cancer Foundation, Dept. of Cell Surface Biochemistry, 120 Northgate Plaza, Suite 218, Seattle, WA 98125, USA.
Glycobiology. 1999 Jul;9(7):637-43. doi: 10.1093/glycob/9.7.637.
An analysis of alpha1-->3fucosyltransferase expression and enzyme properties has been conducted in human lung carcinoma NCI-H69 and PC9 cells. The results indicate that multiple forms of alpha1-->3 fucosyltransferase are found in these cells. RT-PCR experiments using total RNA from NCI-H69 and PC9 cells amplified transcripts for three of these enzymes, FucT-IV, -VI, and -VII. Fucose transfer into glycolipid acceptors mediated by truncated chimeric and full length recombinant FucT-IV and -VI enzymes was examined. Both enzymes were found to be type 2 chain specific, but only FucT-VI efficiently transferred fucose to both neutral and sialylated acceptors. A truncated recombinant form of FucT-VI was capable of fucose transfer to the internal Glc residue of a variety of glycolipid acceptors. This property was not observed with the recombinant full length enzyme, suggesting the N-terminal portion of the protein, composed of the intracellular domain, transmembrane domain, and a part of the stem region, is involved in interactions with glycolipid acceptors. Using taurodeoxycholate as the detergent, the distribution of initial fucose transfer into nLc6catalyzed by recombinant full length enzyme indicated 34% of the mono-fucosyl product was fucosylated at the III-GlcNAc and 66% at the V-GlcNAc for FucT-IV, and almost all of the FucT-VI mono-fucosyl product was III-GlcNAc fucosylated. Similar experiments with VI2NeuAcnLc6as the acceptor resulted in predominantly III-GlcNAc monofucosylation, although detectable V-GlcNAc monofucosylation was obtained with FucT-VI. When the cationic detergent G-3634-A was used, substantially greater initial transfer into the V-GlcNAc of both neutral and sialylated acceptors with FucT-VI was observed. Using nonsialylated acceptors, total alpha1-->3 fucosyltransferase activity in NCI-H69 cells was analyzed and found to be diminished 25-30% by exposure to 30 mM NEM, which can be attributed to FucT-VI inactivation. The remaining 70-75% of NEM-resistant activity is attributed to FucT-IV, an NEM-resistant enzyme form capable of fucosylating nonsialylated acceptors. These results suggest that multiple forms of alpha1-->3fucosyltransferase are expressed in NCI-H69 and PC9 cells, which may account for the observed properties of enzyme derived from these cell lines.
对人肺癌NCI-H69和PC9细胞中的α1→3岩藻糖基转移酶表达及酶特性进行了分析。结果表明,在这些细胞中发现了多种形式的α1→3岩藻糖基转移酶。使用来自NCI-H69和PC9细胞的总RNA进行的RT-PCR实验扩增了其中三种酶FucT-IV、-VI和-VII的转录本。检测了由截短的嵌合型和全长重组FucT-IV和-VI酶介导的岩藻糖向糖脂受体的转移。发现这两种酶均具有2型链特异性,但只有FucT-VI能有效地将岩藻糖转移至中性和唾液酸化受体。截短的重组FucT-VI形式能够将岩藻糖转移至多种糖脂受体的内部Glc残基。全长重组酶未观察到该特性,这表明由细胞内结构域、跨膜结构域和部分茎区组成的蛋白质N端部分参与了与糖脂受体的相互作用。以牛磺脱氧胆酸盐作为去污剂,对全长重组酶催化的向nLc6的初始岩藻糖转移分布进行检测,结果表明,对于FucT-IV,34%的单岩藻糖基化产物在III-GlcNAc处被岩藻糖基化,66%在V-GlcNAc处被岩藻糖基化;而几乎所有FucT-VI的单岩藻糖基化产物都在III-GlcNAc处被岩藻糖基化。以VI2NeuAcnLc6作为受体进行的类似实验导致主要为III-GlcNAc单岩藻糖基化,不过FucT-VI也可检测到V-GlcNAc单岩藻糖基化。当使用阳离子去污剂G-3634-A时,观察到FucT-VI向中性和唾液酸化受体的V-GlcNAc的初始转移显著增加。使用非唾液酸化受体,对NCI-H69细胞中的总α1→3岩藻糖基转移酶活性进行分析,发现暴露于30 mM NEM后活性降低25 - 30%,这可归因于FucT-VI失活。其余70 - 75%的NEM抗性活性归因于FucT-IV,这是一种能够使非唾液酸化受体岩藻糖基化的NEM抗性酶形式。这些结果表明,NCI-H69和PC9细胞中表达了多种形式的α1→3岩藻糖基转移酶,这可能解释了源自这些细胞系的酶所观察到的特性。